Julia Marie Eastland Harpoon Therapeutics, Inc. (HARP) insider trading activity

Julia Marie Eastland is President and CEO of Harpoon Therapeutics, Inc.. Currently has a direct ownership of 0 shares of HARP, which is worth approximately $0. The most recent transaction as insider was on Mar 11, 2024, when has been sold 269,381 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

JULIA MARIE EASTLAND Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 11 2024	SELL Sale (or disposition) back to the issuer	-	269,381 Reduced 100.0%	0 Common Stock
Mar 11 2024	BUY Grant, award, or other acquisition	-	31,250 Added 10.39%	269,381 Common Stock
Jan 07 2024	BUY Grant, award, or other acquisition	-	178,500 Added 43.48%	232,003 Common Stock
Nov 26 2023	BUY Grant, award, or other acquisition	-	50,000 Added 48.31%	53,503 Common Stock

Also insider at

DVAX

DYNAVAX TECHNOLOGIES CORP Healthcare

GRAY

GRAYBUG VISION, INC. Healthcare

Director

LNTH

Lantheus Holdings, Inc. Healthcare

Director

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

CEO & President

JME